Patients on Chronic Hemodialysis Have No Intrinsic Lymphocyte Defect upon Stimulation with Interleukin-2, Interleukin-15 or Tumor Necrosis Factor-Alpha

Tumor Necrosis ◽

Interleukin 2 ◽

Chronic Hemodialysis ◽

Necrosis Factor Alpha ◽

Interleukin 15 ◽

Factor Alpha ◽

Pentoxifylline suppresses interleukin-2-mediated activation of immature human natural killer cells by inhibiting endogenous tumor necrosis factor-alpha secretion

Journal of Clinical Immunology ◽

10.1007/bf01541173 ◽

1994 ◽

Vol 14 (1) ◽

pp. 31-38 ◽

Cited By ~ 16

Author(s):

Anahid Jewett ◽

Benjamin Bonavida

Keyword(s):

Natural Killer Cells ◽

Tumor Necrosis Factor ◽

Natural Killer ◽

Tumor Necrosis ◽

Interleukin 2 ◽

Necrosis Factor Alpha ◽

Human Natural Killer Cells ◽

Factor Alpha ◽

Effects of gamma interferon, tumor necrosis factor alpha, and interleukin-2 on infection and proliferation of Theileria parva-infected bovine lymphoblasts and production of interferon by parasitized cells.

Infection and Immunity ◽

10.1128/iai.59.12.4540-4546.1991 ◽

1991 ◽

Vol 59 (12) ◽

pp. 4540-4546 ◽

Cited By ~ 24

Author(s):

J C DeMartini ◽

C L Baldwin

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Interleukin 2 ◽

Gamma Interferon ◽

Theileria Parva ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Serum Soluble Interleukin-2 Receptor, Interleukin-6 and Tumor Necrosis Factor Alpha as Markers of Celiac Disease Activity

The Indian Journal of Pediatrics ◽

10.1007/s12098-012-0830-9 ◽

2012 ◽

Vol 80 (2) ◽

pp. 108-113 ◽

Cited By ~ 9

Author(s):

Akshay Kapoor ◽

A. K. Patwari ◽

Praveen Kumar ◽

Anju Jain ◽

Shashi Narayan

Keyword(s):

Celiac Disease ◽

Tumor Necrosis Factor ◽

Interleukin 6 ◽

Tumor Necrosis ◽

Interleukin 2 ◽

Necrosis Factor Alpha ◽

Soluble Interleukin 2 Receptor ◽

Factor Alpha ◽

Interleukin-15 (IL-15) enhances the release of interleukin-8 (IL-8), but not of tumor necrosis factor-alpha (TNF-alpha) from unstimulated polymorphonuclear leukocytes and following challenge by Aspergillus species

International Journal of Infectious Diseases ◽

10.1016/s1201-9712(02)90278-x ◽

2002 ◽

Vol 6 ◽

pp. S47-S48

Author(s):

R.M. Winn ◽

A. Maloukou ◽

M. Simitsopoulou ◽

C. Gil-Lamaignere ◽

T.J. Walsh ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Polymorphonuclear Leukocytes ◽

Tumor Necrosis ◽

Interleukin 8 ◽

Tnf Alpha ◽

Necrosis Factor Alpha ◽

Interleukin 15 ◽

Factor Alpha ◽

Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings.

Journal of Clinical Microbiology ◽

10.1128/jcm.29.4.753-756.1991 ◽

1991 ◽

Vol 29 (4) ◽

pp. 753-756 ◽

Cited By ~ 10

Author(s):

R Karttunen ◽

H M Surcel ◽

G Andersson ◽

H P Ekre ◽

E Herva

Keyword(s):

Tumor Necrosis Factor ◽

Francisella Tularensis ◽

Tumor Necrosis ◽

Interleukin 2 ◽

Human Beings ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma

Acta Oto-Laryngologica ◽

10.1080/00016480902849427 ◽

2009 ◽

pp. 1-5 ◽

Cited By ~ 4

Author(s):

Shih-Hsuan Hsiao ◽

Moon-Sing Lee ◽

Hon-Yi Lin ◽

Yu-Chieh Su ◽

Hsu-Chueh Ho ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Tumor Necrosis Factor ◽

Clinical Significance ◽

Tumor Necrosis ◽

Interleukin 2 ◽

Necrosis Factor Alpha ◽

Soluble Interleukin 2 Receptor ◽

Factor Alpha ◽

Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy

Molecular Therapy — Oncolytics ◽

10.1016/j.omto.2016.12.004 ◽

2017 ◽

Vol 4 ◽

pp. 77-86 ◽

Cited By ~ 38

Author(s):

Riikka Havunen ◽

Mikko Siurala ◽

Suvi Sorsa ◽

Susanna Grönberg-Vähä-Koskela ◽

Michael Behr ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Cell Therapy ◽

Tumor Necrosis ◽

Adoptive Cell Therapy ◽

Interleukin 2 ◽

Necrosis Factor Alpha ◽

Oncolytic Adenoviruses ◽

Factor Alpha ◽

Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes.

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.86.7.2331 ◽

1989 ◽

Vol 86 (7) ◽

pp. 2331-2335 ◽

Cited By ~ 108

Author(s):

J. W. Lowenthal ◽

D. W. Ballard ◽

E. Bohnlein ◽

W. C. Greene

Keyword(s):

Gene Expression ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Interleukin 2 ◽

Chain Gene ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor ◽

Receptor Alpha Chain

Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma

Acta Oto-Laryngologica ◽

10.3109/00016480902849427 ◽

2009 ◽

Vol 129 (12) ◽

pp. 1519-1523 ◽

Cited By ~ 11

Author(s):

Shih-Hsuan Hsiao ◽

Moon-Sing Lee ◽

Hon-Yi Lin ◽

Yu-Chieh Su ◽

Hsu-Chueh Ho ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Tumor Necrosis Factor ◽

Clinical Significance ◽

Tumor Necrosis ◽

Interleukin 2 ◽

Necrosis Factor Alpha ◽

Soluble Interleukin 2 Receptor ◽

Factor Alpha ◽

Adenovirus Coding for Interleukin-2 and Tumor Necrosis Factor Alpha Replaces Lymphodepleting Chemotherapy in Adoptive T Cell Therapy

Molecular Therapy ◽

10.1016/j.ymthe.2018.06.001 ◽

2018 ◽

Vol 26 (9) ◽

pp. 2243-2254 ◽

Cited By ~ 14

Author(s):

João Manuel Santos ◽

Víctor Cervera-Carrascon ◽

Riikka Havunen ◽

Sadia Zafar ◽

Mikko Siurala ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Cell Therapy ◽

Tumor Necrosis ◽

Interleukin 2 ◽

Adoptive T Cell Therapy ◽

Necrosis Factor Alpha ◽

T Cell Therapy ◽

Factor Alpha ◽